Acne Treatment Market Size to $13.64 Billion by 2030 |

Puno, Nov. 25, 2022 (GLOBE NEWSWIRE) — According to a new market research report titled “Acne treatment market by drug (retinoids, antibiotics, isotretinoin and others), by drug type (OTC and prescription), by route of administration (oral, topical and injectable), by distribution channel (hospital pharmacies and retail and online pharmacies) – Perspectives and Global Forecasts 2022-2030” published by Growth Plus Reports, the acne treatment market is expected to grow at a pace CAGR or 4.60% from 2021 to be achieved $13.64 billion by 2030.

To get a first-hand overview of the report, request a sample at@

https://growthplusreports.com/inquiry/request-sample/acne-treatment-market/7927

Scope of the report:

Ratio attribute Details
Market size value in 2021 $9.1 billion
Revenue forecast in 2030 13.64 billion US dollars
Rate of growth CAGR of 4.60% from 2022 to 2030
Base year for the estimate 2021
Forecast period 2022-2030
Segments covered Drug, route of administration, distribution channel and region.
regional scope North America, Europe, Asia Pacific and Rest of the World (ROW)

Growth drivers

Acne is a chronic progressive inflammatory condition that affects the face, shoulders and back and affects nearly 95% of adolescents. Several large studies have determined that teenage acne affects 81 to 95 percent of male teenagers and 79 to 82 percent of female teenagers. The incidence of acne is higher among adolescent men than among adolescent women; however, in adults 18 years of age and older, this prevalence rate decreases from age to age for both men and women.

The global acne treatment market was analyzed from four perspectives: drug, route of administration, distribution channel and region

Excerpts from ‘for drugs’

On the basis of the drug, the global acne treatment market has been segmented into

  • Retinoids
  • Antibiotics
  • Isotretinoin
  • Other

Because the increased approval of antibiotic drugs for the treatment of acne and the introduction of new dosage forms of antibiotics such as lotions, creams and powders contribute to the growth of the antibiotic segment in the global acne treatment market. Retinoids are also expected to grow at an exponential rate over the forecast period due to the increased use of retinol for acne and skin treatment and other retinol benefits, such as collagen stimulation and production of elastin.

Excerpts from “by type of drug”

The global acne treatment market based on drug type has been segmented into

  • Over the counter (OTC)
  • prescription

The over-the-counter (OTC) segment dominates the global acne treatment market due to easily obtainable medications, time and money savings, no prescription, and high therapeutic properties. Also, many online drugstores and pharmacies contribute significantly to the growth of the global over-the-counter acne treatment market. Under the brand name MINYM, Glenmark Pharma launched India’s first 4% minocycline topical gel in July 2022 for the treatment of severe to moderate acne.

Extracts from ‘segmentation by region

The global acne treatment market has been segmented into

  • North America
  • Europe
  • Asia Pacific
  • The rest of the world

North America and Asia Pacific dominate the global acne treatment market. North America’s large share of the global market is attributed to a growing number of drugs approved for acne treatment, growing social media penetration, and growing adoption of new drug treatments.

Excerpts from “Competitive Landscape”

The major players in the global acne treatment market are

  • Charles River Laboratories International, Inc.
  • Clean cells
  • Eurofins Scientific Se
  • Kedrion SPA
  • Merck Kgaa
  • Sartorio Ag
  • Texcell Sa
  • Vironova Ab
  • Virusure GmbH
  • Wuxi organic products

Do you have questions? Ask our experts:

https://growthplusreports.com/inquiry/before-buying/acne-treatment-market/7927

Table of contents

  1. INTRODUCTION
    1. Market ecosystem
    2. Chronology under review
      1. Historic Years – 2020
      2. Base year – 2021
      3. Planned years: 2022 to 2030
    3. Currency used in the report
  2. RESEARCH METHODOLOGY
    1. Research approach
    2. Data collection methodology
    3. Data origin
      1. Secondary sources
      2. Primary sources
    4. Approach to market estimation
      1. Bottom up
      2. Upside down
    5. Market prediction model
    6. Limitations and assumptions
  3. PREMIUM INSIGHTS
    1. Current market trends (COVID-19 perspective)
    2. Key Players and Competitive Positioning (2021)
  4. MARKET DYNAMICS
    1. Drivers
    2. Restrictions/Challenges
    3. Chance
  5. GLOBAL ACNE TREATMENT MARKET – ANALYSIS AND FORECAST, BY MEDICATION
    1. Retinoids
    2. Antibiotics
    3. Isotretinoin
    4. Other
  6. GLOBAL ACNE TREATMENT MARKET – ANALYSIS AND FORECAST, BY MEDICATION TYPE
    1. OTC
    2. prescription
  7. GLOBAL ACNE TREATMENT MARKET – ANALYSIS AND FORECASTS, BY ADMINISTRATION ROUTE
    1. oral
    2. topical
    3. Injectable

Table of Contents Continue…

VALUE PROPOSITIONS RELATED TO THE REPORT:

  • Powered with hours of free analysis and expert interviews with every report
  • Comprehensive quantitative and qualitative insights at the segment and sub-segment level
  • Covid 19 impacts trends and perspectives
  • Granular insights at global/regional/country level
  • In-depth insights into market dynamics (drivers, constraints, opportunities) and the business environment
  • Global coverage of the competitive landscape
  • Winning imperatives
  • Comprehensive coverage of the “strategic developments” recorded by the main market players

CUSTOMIZATION OPTIONS:

  • Distributor landscape assessment
  • conduct assessment
  • Pricing intelligence
  • Evaluation of the customer base
  • Analysis of investments and initiatives
  • “Company profile” or key players

Click on the following link to purchase the Acne Treatment Market:

https://growthplusreports.com/checkout?_token=UJSHqBVeemUM4xq0eeC6Obdcj3Dw0u8wA2eQevzx&report_id=7927&license=Single

Who we are

Growth Plus Reports is part of GRG Health, a global health knowledge services company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

The Growth+ portfolio of services draws on our core capabilities in secondary and primary research, market modeling and forecasting, benchmarking, analysis and strategy formulation to help clients create scalable and game-changing solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO magazine as “Most Innovative Healthcare Market Research Firm 2020.

        

.

Leave a Comment

%d bloggers like this: